EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Targeted Therapies in Colorectal Cancer: Recent Advances in Biomarkers, Landmark Trials, and Future Perspectives

Joao Manzi iD, Camilla O Hoff iD, Raphaella Ferreira iD, Agustin Pimentel, Jashodeep Datta, Alan S Livingstone, Rodrigo Vianna, Phillipe Abreu iD

Cancers · 01.06.2023 · 15 (11) · 3023

DOI: 10.3390/cancers15113023 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 01.06.2023. Verfasst von Joao Manzi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Miami Transplant Institute, Jackson Memorial Hospital, University of Miami, Miami, FL 33136, USA. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 159 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In 2022, approximately 600,000 cancer deaths were expected; more than 50,000 of those deaths would be from colorectal cancer (CRC). The CRC mortality rate in the US has decreased in recent decades, with a 51% drop between 1976 and 2014. This drop is attributed, in part, to the tremendous therapeutic improvements, especially after the 2000s, in addition to increased social awareness regarding risk factors and diagnostic improvement. Five-fluorouracil, irinotecan, capecitabine, and later oxaliplatin were the mainstays of mCRC treatment from the 1960s to 2002. Since then, more than a dozen drugs have been approved for the disease, betting on a new chapter in medicine, precision oncology, which uses patient and tumor characteristics to guide the therapeutic choice. Thus, this review will summarize the current literature on targeted therapies, highlighting the molecular biomarkers involved and their pathways.

Schlagwörter

Stichwörter der Autor:innen

biomarkerscolorectal cancercolorectal liver metastasisliver transplantoncologysurgical oncology

Autor:innen und Institutionen

  • Miami Transplant Institute, Jackson Memorial Hospital, University of Miami, Miami, FL 33136, USA.
  • Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL 33136, USA.

ORCID-Profile: Joao Manzi, Camilla O Hoff, Raphaella Ferreira, Phillipe Abreu

Zitieren

APA

Manzi, J., Hoff, C. O., Ferreira, R., Pimentel, A., Datta, J., Livingstone, A. S., Vianna, R., & Abreu, P. (2023). Targeted Therapies in Colorectal Cancer: Recent Advances in Biomarkers, Landmark Trials, and Future Perspectives. Cancers, 15(11), 3023. https://doi.org/10.3390/cancers15113023

Vancouver

Manzi J, Hoff CO, Ferreira R, Pimentel A, Datta J, Livingstone AS, et al. Targeted Therapies in Colorectal Cancer: Recent Advances in Biomarkers, Landmark Trials, and Future Perspectives. Cancers. 2023;15(11):3023. doi:10.3390/cancers15113023

BibTeX
@article{Manzi2023,
  author = {Manzi, Joao and Hoff, Camilla O and Ferreira, Raphaella and Pimentel, Agustin and Datta, Jashodeep and Livingstone, Alan S and Vianna, Rodrigo and Abreu, Phillipe},
  title = {Targeted Therapies in Colorectal Cancer: Recent Advances in Biomarkers, Landmark Trials, and Future Perspectives},
  journal = {Cancers},
  year = {2023},
  volume = {15},
  number = {11},
  pages = {3023},
  doi = {10.3390/cancers15113023}
}
Kostenlos starten →